Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Lung Cancer (Amsterdam, Netherlands)|November 27, 2001
New agents within the preoperative chemotherapy of non-small cell lung cancerM Krzakowski
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 12, 2008
Epoetin delta: efficacy in the treatment of anaemia in cancer patients receiving chemotherapyM Krzakowski,
Nowotwory|April 1, 1990
[Early results of combined treatment (induction chemotherapy and radiotherapy) of patients with squamous cell carcinoma of the oropharynx]Z Szutkowski, M Krzakowski, A Hliniak, et al.
Seminars in Oncology|October 1, 1994
A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesisG Madej, M Krzakowski, A Pawinski, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 15, 2017
Pathophysiology and clinical characteristics of pain in most common locations in cancer patientsW Leppert, R Zajaczkowska, J Wordliczek, et al.
Cancer Chemotherapy and Pharmacology|November 14, 2013
Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancerM Krzakowski, J Bennouna, E Dansin, et al.
Anti-Cancer Drugs|October 17, 1998
A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Ondansetron Acute Emesis Study GroupM Krzakowski, E Graham, L Goedhals, et al.
Cytokines, Cellular & Molecular Therapy|August 13, 2002
Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapyS Markowicz, J Walewski, K Zajda, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal womenI Vergote, J Bonneterre, B Thürlimann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability studyJ Bonneterre, B Thürlimann, J F Robertson, et al.
Pageof 3